HOME >> MEDICINE >> NEWS
National Academies news: Clinical research involving children

WASHINGTON -- Federal rules to protect children from risky or unethical clinical research should be extended to cover all pediatric research in the public and private sectors, says a new report from the Institute of Medicine of the National Academies. Currently, the rules apply primarily to studies that are supported by the U.S. Department of Health and Human Services or regulated by the Food and Drug Administration. Some research institutions voluntarily apply them to their studies.

The report also says that the government should offer better guidance and in more accessible formats to clinical researchers and institutional review boards (IRBs) to help them interpret the federal rules, which are more restrictive for children than adults. In turn, IRBs which are responsible for approving human research should be more thorough and explicit in judging whether research involving children meets the highest ethical and scientific standards. On the whole, as clinical research has grown in scope and complexity, implementing human-research protection policies consistently and effectively has become more challenging.

"Involving more children in clinical research today will benefit the health and well-being of countless children in the future, but unlike most adults, children usually lack the legal right and the intellectual and emotional maturity to consent to research participation on their own behalf," said committee chair Richard E. Behrman, executive chair of the Pediatric Education Steering Committee of the Federation of Pediatric Organizations, Palo Alto, Calif., and clinical professor of pediatrics at both the University of California, San Francisco, and George Washington University, Washington, D.C. "Their vulnerability demands additional protections beyond those provided to mentally competent adults."

THE GROWTH OF RESEARCH INVOLVING CHILDREN

Congress, the National Institutes of Health, and FDA have taken steps in rec
'"/>

Contact: Vanee Vines
news@nas.edu
202-334-2138
The National Academies
26-Mar-2004


Page: 1 2 3 4 5

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
3. National Academies news: Academy honors 17 for major contributions to science
4. National Academies advisory: Report assesses health implications of perchlorate exposure
5. National Academies Advisory: Jan. 11 public briefing on perchlorate in drinking water
6. National Academies news: Gulf War and Health
7. National survey shows few physicians elected to Congress
8. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
9. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. National Chemistry Week celebrates health and wellness in Washington, D.C., area

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: National Academies news Clinical research involving children

(Date:6/18/2013)... The new swab, designed for infants ... the tip allowing for faster collection of infant saliva. ... (SIS) can be tested for cortisol, cotinine, testosterone, ... diameter of the Salimetrics Infant Swab has been increased ... access more saliva in the newborn’s mouth and thereby ...
(Date:6/17/2013)... (PRWEB) June 18, 2013 A ground-breaking ... stroke patients a new rehabilitation treatment. , Constraint ... and offers a new intensive rehabilitation program to help ... those with cerebral palsy and some other neurological conditions. ... “rewires” the brain helping people to improve the use ...
(Date:6/17/2013)... IL (PRWEB) June 17, 2013 The ... after mild traumatic brain injury (MTBI) closely resembles that ... study published online in the journal Radiology. , ... seen in early Alzheimer’s dementia,” said the study’s lead ... the Division of Neuroradiology at the University of Pittsburgh ...
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... distribution of white matter brain abnormalities in some patients ... found in early Alzheimer,s dementia, according to a new ... , "Findings of MTBI bear a striking resemblance ... study,s lead author, Saeed Fakhran, M.D., assistant professor of ... of Pittsburgh School of Medicine. "Additional research may help ...
Breaking Medicine News(10 mins):Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:Revolutionary Treatment for Stroke Now Available in Western Australia 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3
(Date:6/17/2013)... 2013 Breezy , a portfolio ... product this week using a platform technology enabling innovative treatment ... (bad breath) is being sold in major Israeli pharmacy chains ... launch in Israel follows similar successful ... Spain earlier this year, with a repeat ...
(Date:6/17/2013)... NEW BRUNSWICK, N.J. , June 17, 2013 ... JNJ ) announced today a definitive agreement to ... and development company focused on drugs to treat ... Aragon,s androgen receptor antagonist program.  Aragon,s lead product ... inhibitor, ARN-509, in Phase 2 development for castration ...
(Date:6/17/2013)... 2013  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... acquisition of intellectual property (IP) rights related to ... of Ohio -based Buderer Drug ... commercial development of these proprietary innovations and also ... on additional Buderer Drug Company intellectual property and ...
Breaking Medicine Technology:A Big "LIKE" for Oral Hygiene 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5
Cached News: